AndroGel Cost in Montana 2026: Cash Price, Insurance, Medicaid, and Cheaper Alternatives

What Does AndroGel Actually Cost in Montana in 2026?

The cash price for AndroGel 1.62% at Montana retail pharmacies runs approximately $510 per month in 2026 for a standard 30-day supply at the 40.5 mg starting dose. That figure reflects the AbbVie manufacturer list price and aligns with national average wholesale pricing data. Patients paying out of pocket without any coupon or assistance program face that full amount at chains including Walmart, Walgreens, and independent pharmacies in Billings, Missoula, and Great Falls.

Generic testosterone gel 1% (the original AndroGel formulation) is available at some Montana pharmacies for roughly $180 to $220 per month cash, depending on the dispensing pharmacy and quantity. The 1% formulation requires a larger volume applied to the skin compared with the 1.62% gel, but the active hormone delivered is the same. The FDA approved the original 1% testosterone gel in 2000 and the 1.62% formulation in 2011 under NDA 021015 and NDA 202763, respectively. Both labels are available at the FDA's drug database [1].

Testosterone replacement therapy is indicated for males with classical hypogonadism confirmed by two morning serum total testosterone measurements below 300 ng/dL, along with consistent signs and symptoms, per the American Urological Association guideline [2]. The T-Trials (N=788 men aged 65 and older, mean baseline testosterone 234 ng/dL) demonstrated that testosterone treatment for 12 months improved sexual function scores, walking distance, and bone mineral density compared with placebo, with a mean testosterone increase of 296 ng/dL in the treated group (P<0.001) [3].

Prices vary by pharmacy. Always request the pharmacist run your specific NDC through GoodRx or a similar coupon aggregator before paying the sticker price.

Does Montana Medicaid Cover AndroGel?

Montana Medicaid does not cover AndroGel or generic testosterone gel for male hypogonadism as of 2026. The Montana Department of Public Health and Human Services Preferred Drug List excludes brand-name AndroGel, and testosterone gel formulations for hypogonadism are not on the Medicaid fee-for-service formulary for adult males in the state.

This exclusion is consistent with a broader national Medicaid pattern. A 2019 analysis in the Journal of Clinical Endocrinology and Metabolism found that testosterone therapy for male hypogonadism faced significant coverage restrictions across state Medicaid programs, with many programs requiring prior authorization or excluding brand-name products entirely [4]. Montana sits among the more restrictive states.

Patients enrolled in Montana Medicaid who have a documented diagnosis of hypogonadism may submit a prior authorization request, but approval for AndroGel brand specifically is unlikely based on current formulary structure. Testosterone cypionate injection (a cheaper alternative administered every 1 to 2 weeks) may qualify for Medicaid coverage in Montana because it is a low-cost generic injectable, and clinicians sometimes recommend it for Medicaid patients when gel is not covered [5].

The decision framework below outlines how Montana clinicians and patients typically manage coverage:

1. Confirm hypogonadism with two morning total testosterone draws and clinical symptoms per Endocrine Society guidelines [6].
2. Check private insurance formulary before prescribing brand-name AndroGel.
3. If Medicaid, request prior authorization and document the clinical necessity. Expect denial; appeal with laboratory data.
4. If denied or uninsured, evaluate compounded testosterone gel from a 503A pharmacy or generic testosterone gel as cost-reduction options.
5. For commercially insured patients, apply the AbbVie savings card at point of sale.

Which Insurance Plans Cover AndroGel in Montana?

Coverage depends entirely on the specific plan and formulary tier. Most commercial insurers operating in Montana, including Blue Cross Blue Shield of Montana, PacificSource, and SelectHealth, place AndroGel on Tier 3 or Tier 4 of their formularies, meaning patient cost-sharing typically runs $60 to $150 per month after deductible. Some plans require prior authorization, step therapy through a generic testosterone gel first, or a quantity limit of one 75 g pump bottle per 30 days.

Medicare Part D plans vary widely. The CMS formulary search tool at cms.gov lists plan-by-plan coverage. In 2024, about 60% of Part D plans covered some form of testosterone gel with prior authorization, though AndroGel brand specifically had lower coverage rates than generic alternatives [7].

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy states: "We suggest using testosterone formulations that are affordable and acceptable to the patient" [6]. That practical language exists precisely because cost is a real barrier. No single formulation is clinically superior for most patients, which means prior-auth step therapy requiring generic testosterone gel first is medically defensible and acceptable.

Prior authorization forms for Montana commercial plans typically require:

• Two fasting morning serum total testosterone values below 300 ng/dL drawn at least two weeks apart
• Documentation of signs or symptoms (fatigue, low libido, loss of muscle mass, or erectile dysfunction)
• Prescriber attestation that the diagnosis meets ICD-10 code E29.1 (testicular hypofunction)

Submitting complete documentation on the first request reduces the appeal rate significantly. Practices in Billings and Missoula that specialize in men's health typically submit these forms with labs already attached.

How Does the AbbVie Savings Card Work in Montana?

AbbVie offers the AndroGel myAbbVie Assist savings card for commercially insured patients. Eligible patients pay as little as $0 per month on their first fill and no more than a defined maximum co-pay on subsequent fills, subject to program terms that AbbVie updates annually. The savings card is available at abbvie.com/patients and can be activated before the first prescription is filled.

Key eligibility rules: the patient must have commercial insurance (not Medicaid, Medicare, or any government-funded insurance), must be a U.S. resident, and the AndroGel prescription must be for an FDA-approved indication. Montana patients qualify under these terms as long as they meet the commercial insurance requirement [8].

The card does not work at mail-order pharmacies in all cases. Confirm with your Montana retail pharmacy that they accept the AbbVie savings card before submitting the prescription.

Patients without commercial insurance who cannot afford AndroGel may apply for the AbbVie Patient Assistance Foundation program, which can provide the medication at no cost for qualifying low-income patients. Applications require income documentation and are processed through the prescriber's office [8].

Is Compounded Testosterone Gel Legal in Montana?

Compounded testosterone gel is legal in Montana when dispensed by a licensed 503A compounding pharmacy operating under state Board of Pharmacy oversight. Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacies to compound testosterone gel for individual patients based on a valid prescription from a licensed prescriber. The compound must be patient-specific, not manufactured in bulk for general sale [9].

Montana does not have its own compounding statute that is more restrictive than federal 503A rules, so any pharmacy licensed by the Montana Board of Pharmacy and operating under 503A can compound testosterone gel for Montana patients. Several telehealth-connected compounding pharmacies ship to Montana addresses, and local compounding pharmacies in Billings and Missoula also compound testosterone gel.

The FDA's 2023 guidance on compounded testosterone products clarifies that testosterone is not on the FDA's list of drugs that may not be compounded, meaning its compounding remains permissible as long as the pharmacy meets 503A requirements [9]. The compounded gel is not AB-rated as bioequivalent to AndroGel by the FDA, which matters for insurance substitution purposes but not for clinical use under a direct prescription.

Cost comparison is stark. Compounded testosterone gel (typically 100 mg/mL or 200 mg/mL base) from a Montana 503A pharmacy runs approximately $120 per month for a 30-day supply at a standard therapeutic dose, compared with $510 per month for brand-name AndroGel. That is roughly 76% lower cost for the same active hormone [10].

Quality matters with compounding. Patients should confirm their pharmacy has passed a recent USP 795/797 inspection and participates in a third-party potency-testing program. The FDA's adverse event reporting system (FAERS) has received reports of variable potency from some compounding operations, though this is uncommon with accredited 503A pharmacies [9].

Can I Get AndroGel Via Telehealth in Montana?

Telehealth prescribing of testosterone gel is legal in Montana. The Montana Board of Medical Examiners permits prescribing of Schedule III controlled substances (which includes testosterone) via telehealth when the prescriber has established a valid patient-physician relationship, conducted an appropriate clinical evaluation including review of laboratory results, and documented the encounter in a medical record [11].

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 requires that a prescriber conduct at least one in-person evaluation before prescribing Schedule III through V controlled substances via telemedicine, unless a DEA exception applies. Montana is one of the states that has also adopted telemedicine-specific prescribing regulations that align with the federal Ryan Haight requirements [11]. During the COVID-19 public health emergency, the DEA issued waivers allowing first-time testosterone prescriptions via telehealth without an in-person visit. Those waivers have been subject to ongoing rulemaking; clinicians should verify current DEA policy before prescribing.

Practical steps for Montana patients seeking testosterone therapy via telehealth:

1. Order baseline labs (total testosterone, LH, FSH, CBC, PSA, and hematocrit) at a local LabCorp or Quest location in Montana.
2. Schedule a telehealth visit with a licensed Montana prescriber or a platform operating under Montana licensure.
3. Receive the prescription electronically, which can be sent to a retail pharmacy in Montana or to a licensed compounding pharmacy.
4. Follow up at 6 weeks with repeat serum testosterone drawn 2 to 4 hours after morning application to confirm target levels of 400 to 700 ng/dL per the Endocrine Society guideline [6].

What Are the Cheapest Ways to Get Testosterone Gel in Montana?

Cost reduction options rank roughly as follows for Montana patients in 2026:

Compounded testosterone gel via 503A pharmacy: ~$120/month. This is the lowest-cost path for uninsured or underinsured patients. Requires a valid prescription and a willing compounding pharmacy. No insurance needed [10].

Generic testosterone gel 1% with GoodRx coupon: ~$90 to $180/month. GoodRx and similar coupon platforms negotiate discounts at retail pharmacies. The cash price with a GoodRx coupon for generic testosterone gel 1% at Montana pharmacies ranged from $90 to $185 per month in mid-2025, depending on location and pharmacy. Check goodrx.com directly for current zip-code-specific pricing [12].

Brand AndroGel with AbbVie savings card (commercially insured): as low as $0 to $35/month. This is the best deal for patients who already have commercial insurance and meet eligibility criteria [8].

Brand AndroGel with insurance (Tier 3): ~$60 to $150/month after deductible. Requires formulary coverage and possibly prior authorization.

Testosterone cypionate injection (for Medicaid or very cost-sensitive patients): ~$30 to $60/month. Generic injectable testosterone cypionate 200 mg/mL is the most affordable prescription testosterone option and may be covered by Montana Medicaid in some circumstances. It requires intramuscular injection every 1 to 2 weeks, which some patients prefer to avoid [5].

A 2022 study in JAMA Internal Medicine found that GLP-1 and TRT cash prices across states varied by as much as 300% depending on pharmacy choice within the same ZIP code, reinforcing the value of price comparison before filling any prescription [13].

Monitoring Requirements After Starting AndroGel in Montana

Starting AndroGel or any testosterone gel requires follow-up laboratory testing. The FDA-approved prescribing information for AndroGel 1.62% specifies checking serum testosterone 2 weeks after initiation or dose adjustment, with a target of 400 to 700 ng/dL (measured 2 to 4 hours after morning application) [1].

The Endocrine Society 2018 guideline recommends monitoring hematocrit at baseline, at 3 to 6 months, and then annually, because supraphysiologic testosterone can stimulate erythropoiesis and raise thrombotic risk when hematocrit exceeds 54% [6]. The guideline also recommends PSA testing at baseline and at 3 to 6 months for men over age 40, given the theoretical risk of stimulating occult prostate cancer, though the TRAVERSE trial (N=5,246) found no statistically significant increase in major adverse cardiovascular events or prostate cancer incidence over a mean 33 months of testosterone treatment in men with hypogonadism and pre-existing or high-risk cardiovascular disease [14].

PSA monitoring is particularly relevant in Montana, where rural access to urologists is limited. A rising PSA above 1.4 ng/mL from baseline within 12 months of starting testosterone, or a PSA above 4.0 ng/mL at any point, warrants urological referral per the Endocrine Society guideline [6].

Lab work in rural Montana can be ordered through LabCorp or Quest locations in larger cities, or through the Indian Health Service labs serving tribal communities. Many telehealth testosterone platforms include lab ordering as part of their service, which simplifies monitoring for patients in remote counties.

Side Effects and Contraindications Relevant to Montana Patients

Testosterone gel carries a black-box FDA warning for secondary exposure: children and women who come into contact with application sites on the skin of treated men can absorb testosterone and experience virilization. The FDA issued a safety communication on this in 2009 after pediatric virilization cases were reported [1]. Montana patients should apply gel to the shoulders or upper arms, cover the area with clothing after the gel dries, and wash hands thoroughly after application.

Contraindications to testosterone therapy include:

• Breast or prostate cancer (known or suspected)
• Male infertility in men who wish to remain fertile (testosterone suppresses LH and FSH, reducing spermatogenesis; gonadotropins or clomiphene are preferred in this population) [15]
• Hematocrit above 54% at baseline
• Uncontrolled obstructive sleep apnea
• Severe lower urinary tract symptoms with IPSS score above 19

A 2016 meta-analysis in the Annals of Internal Medicine (N=3,016 men across 58 trials) found that testosterone therapy increased hematocrit by a mean of 3.2 percentage points vs. placebo, and raised PSA by 0.18 ng/mL, with no statistically significant effect on cardiovascular events in this dataset [16]. The more recent TRAVERSE trial data published in NEJM in 2023 provides the most rigorous cardiovascular safety evidence to date [14].

Comparing AndroGel to Other Testosterone Formulations Available in Montana

Montana prescribers have access to the full range of FDA-approved testosterone formulations. The cost and delivery method differ substantially:

Testosterone cypionate injection (brand: Depo-Testosterone): Generic available. Cost ~$30 to $60/month. Administered IM every 1 to 2 weeks or as a weekly subcutaneous injection. Produces peaks and troughs in serum testosterone. Most affordable formulation [5].

Testosterone enanthate injection (brand: Xyosted): Subcutaneous auto-injector. Cost ~$300 to $400/month brand. Generic testosterone enanthate for compounding is cheaper. Smoother levels than cypionate for many patients [17].

Testosterone undecanoate injection (brand: Aveed): Long-acting IM injection every 10 weeks after loading doses. Requires in-office administration due to REMS program (pulmonary oil microembolism risk). Cost ~$1,200 to $1,500 per injection [1].

Testosterone pellets (brand: Testopel): Subcutaneous implant every 3 to 6 months. In-office procedure. Cost ~$500 to $800 per insertion procedure. Not all Montana clinicians perform the procedure [18].

Topical testosterone gel (AndroGel, generics, compounded): Daily application. Cost ranges from ~$90 (generic with coupon) to $510 (brand cash) per month. Most commonly prescribed formulation in the United States [1].

The T-Trials investigators chose transdermal testosterone gel as their primary delivery method for the trial population of older men, noting that daily gel application produced stable serum levels that were easier to monitor than injection formulations [3]. For Montana patients in remote areas who cannot reach an office for injections, gel or self-administered subcutaneous injections offer the most practical options.